Burning Rock and CStone Pharmaceuticals reached a strategic collaboration on the co-development of companion diagnostics for pralsetinib in China SHANGHAI, China, June 28, 2020 (GLOBE NEWSWIRE) -- On June 29, 2020, Burning Rock Biotech Limited (NASDAQ: BNR) announced a strategic partnership with CStone Pharmaceuticals (HKEX: 2616) to...

Burning Rock Announces Full Exercise of Over-Allotment Option in Initial Public Offering GUANGZHOU, China, June 22, 2020 (GLOBE NEWSWIRE) -- Burning Rock Biotech Limited (“Burning Rock” or the “Company”) (NASDAQ: BNR), a company focused on the application of next generation sequencing...

Burning Rock Announces Pricing of Initial Public Offering GUANGZHOU, China, June 12, 2020 (GLOBE NEWSWIRE) -- Burning Rock Biotech Limited (“Burning Rock” or the “Company”), a company focused on the application of next generation sequencing (NGS)...

Burning Rock deepens cooperation with Illumina to promote development and standardization of NGS-based cancer therapy selection in China SHANGHAI, China, May 10, 2020 (GLOBE NEWSWIRE) -- Burning Rock and Illumina (NASDAQ: ILMN), a global leader in gene sequencing and array-based technologies, jointly announced today that they are...

Burning Rock initiates the first prospective, multi-center pan-cancer early detection study in China SHANGHAI, China, May 07, 2020 (GLOBE NEWSWIRE) -- Burning Rock today announces the initiation of its 14,000 patient PREDICT (Pan-CanceR Early DetectIon ProjeCT) study to further develop and validate...